04/23/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
3:45 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/08/2024
3:45 PM | Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:30 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
03/27/2024
3:20 PM | Seres Therapeutics (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
9:01 AM | Seres Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
9:13 AM | Seres Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
9:18 AM | Seres Therapeutics (Filer)
| Form DEF 14A | |
03/05/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:06 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
8:48 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:42 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:21 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:29 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:31 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:13 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:15 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:23 AM | JANUS HENDERSON GROUP PLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:01 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G | |
01/10/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
11:57 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
11/02/2023
9:00 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
8:36 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:36 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:39 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:39 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:39 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:40 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:40 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:43 PM | Cloghessy Paula (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
08/15/2023
11:15 PM | Seres Therapeutics (Filer)
| Form EFFECT | |
08/08/2023
9:01 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
7:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
4:29 PM | Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:35 PM | Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:21 PM | Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:21 PM | Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:22 PM | Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:24 PM | Behar Gregory (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:25 PM | Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:25 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
9:16 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
05/09/2023
9:00 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
7:16 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
3:41 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2023
3:43 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/27/2023
6:26 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
